318 related articles for article (PubMed ID: 32319154)
1. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study.
Li J; Fairhurst C; Peckham E; Bailey D; Arundel C; Hewitt C; Heron P; Crosland S; Parrott S; Gilbody S;
Addiction; 2020 Nov; 115(11):2113-2122. PubMed ID: 32319154
[TBL] [Abstract][Full Text] [Related]
2. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
[TBL] [Abstract][Full Text] [Related]
3. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial.
Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S
Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207
[TBL] [Abstract][Full Text] [Related]
5. Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR+): study protocol for a randomised controlled trial.
Peckham E; Arundel C; Bailey D; Brownings S; Fairhurst C; Heron P; Li J; Parrott S; Gilbody S
Trials; 2017 Jan; 18(1):44. PubMed ID: 28126031
[TBL] [Abstract][Full Text] [Related]
6. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
Gilbody S; Peckham E; Bailey D; Arundel C; Heron P; Crosland S; Fairhurst C; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C
Lancet Psychiatry; 2019 May; 6(5):379-390. PubMed ID: 30975539
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial.
Wu Q; Gilbert H; Nazareth I; Sutton S; Morris R; Petersen I; Galton S; Parrott S
Addiction; 2018 Apr; 113(4):708-718. PubMed ID: 29105871
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion.
Heslin M; Patel A; Stahl D; Gardner-Sood P; Mushore M; Smith S; Greenwood K; Onagbesan O; O'Brien C; Fung C; Ohlsen R; Hopkins D; Lowe P; Arbuthnot M; Mutatsa S; Todd G; Kolliakou A; Lally J; Stubbs B; Ismail K; David A; Murray R; Atakan Z; Gaughran F
BMC Psychiatry; 2017 Dec; 17(1):407. PubMed ID: 29273021
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial.
Li J; Parrott S; Keding A; Dogar O; Gabe R; Marshall AM; Huque R; Barua D; Fatima R; Khan A; Zahid R; Mansoor S; Kotz D; Boeckmann M; Elsey H; Kralikova E; Readshaw A; Sheikh A; Siddiqi K;
BMJ Open; 2022 Aug; 12(8):e049644. PubMed ID: 36028279
[TBL] [Abstract][Full Text] [Related]
11. Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services.
Gilbert H; Sutton S; Morris R; Petersen I; Wu Q; Parrott S; Galton S; Kale D; Magee MS; Gardner L; Nazareth I
Health Technol Assess; 2017 Jan; 21(3):1-206. PubMed ID: 28121288
[TBL] [Abstract][Full Text] [Related]
12. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
das Nair R; Bradshaw LE; Carpenter H; Clarke S; Day F; Drummond A; Fitzsimmons D; Harris S; Montgomery AA; Newby G; Sackley C; Lincoln NB
Health Technol Assess; 2019 Apr; 23(16):1-194. PubMed ID: 31032782
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and cost-utility analysis of a work-place smoking cessation intervention with and without financial incentives.
van den Brand FA; Nagelhout GE; Winkens B; Chavannes NH; van Schayck OCP; Evers SMAA
Addiction; 2020 Mar; 115(3):534-545. PubMed ID: 31849138
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial.
Barnett PG; Wong W; Jeffers A; Hall SM; Prochaska JJ
J Clin Psychiatry; 2015 Oct; 76(10):e1285-91. PubMed ID: 26528651
[TBL] [Abstract][Full Text] [Related]
15. Nicotine preloading for smoking cessation: the Preloading RCT.
Aveyard P; Lindson N; Tearne S; Adams R; Ahmed K; Alekna R; Banting M; Healy M; Khan S; Rai G; Wood C; Anderson EC; Ataya-Williams A; Attwood A; Easey K; Fluharty M; Freuler T; Hurse M; Khouja J; Lacey L; Munafò M; Lycett D; McEwen A; Coleman T; Dickinson A; Lewis S; Orton S; Perdue J; Randall C; Anderson R; Bisal N; Hajek P; Homsey C; McRobbie HJ; Myers-Smith K; Phillips A; Przulj D; Li J; Coyle D; Coyle K; Pokhrel S
Health Technol Assess; 2018 Aug; 22(41):1-84. PubMed ID: 30079863
[TBL] [Abstract][Full Text] [Related]
16. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
[TBL] [Abstract][Full Text] [Related]
17. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
18. Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial.
Gilbody S; Peckham E; Man MS; Mitchell N; Li J; Becque T; Hewitt C; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C
Lancet Psychiatry; 2015 May; 2(5):395-402. PubMed ID: 26360283
[TBL] [Abstract][Full Text] [Related]
19. Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD.
Cheung KL; Wijnen BFM; Hiligsmann M; Coyle K; Coyle D; Pokhrel S; de Vries H; Präger M; Evers SMAA
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):87-95. PubMed ID: 29243351
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.
Barnett PG; Jeffers A; Smith MW; Chow BK; McFall M; Saxon AJ
Nicotine Tob Res; 2016 Mar; 18(3):267-74. PubMed ID: 25943761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
